Lu Yu

Lu Yu

Auto-generated profile, based on publicly available information

Lu Yu

School of Molecular Sciences and Center for Molecular Design and Biomimetics, The Biodesign Institute, Arizona State University, Tempe, Arizona 85281, United States

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
LYLu Yu
Lu Yu
YXYang Xu
Yang Xu
AAAl- Amin
Al- Amin
SJShuoxing Jiang
Shuoxing Jiang
MSMatthew Sample
Matthew Sample
HYHao Yan
Hao Yan

17 June 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
YTYue Tang
Yue Tang
HLHao Liu
Hao Liu
QWQi Wang
Qi Wang
XQXiaodong Qi
Xiaodong Qi
LYLu Yu
Lu Yu
SJShuoxing Jiang
Shuoxing Jiang

27 July 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KDKun Dai
Kun Dai
YXYang Xu
Yang Xu
YYYang Yang
Yang Yang
JSJianfeng Shen
Jianfeng Shen
XLXiaoguo Liu
Xiaoguo Liu
GYGuangbao Yao
Guangbao Yao

27 July 2023 in Nano Letters
Verified
Journal Article
Closed access
KDKun Dai
Kun Dai
CGChen Gong
Chen Gong
YXYang Xu
Yang Xu
FDFei Ding
Fei Ding
XQXiaodong Qi
Xiaodong Qi
GYGuangbao Yao
Guangbao Yao

30 October 2025 in JACS Au
Verified
Journal Article
Open access
XTXinyi Tu
Xinyi Tu
LYLu Yu
Lu Yu
LZLanshen Zhao
Lanshen Zhao
XQXiaodong Qi
Xiaodong Qi
YXYang Xu
Yang Xu
HYHao Yan
Hao Yan
The advancement of cancer immunotherapy has focused on developing therapies that not only target tumor progression but also enhance immune responses, which could potentially shift the balance within the tumor microenvironment (TME) to promote a more immune-competent environment and improve the effectiveness of antitumor immunotherapies. This study evaluates the internalization of single-stranded RNA origami (ssRNAOG) in coculture models mimicking the TME in vitro and the antitumor efficacy of the combination of ssRNAOG with 5-fluorouracil (5-FU) in pancreatic ductal adenocarcinoma (PDAC) models. The internalization of ssRNAOG triggers the TLR3 signaling pathway, leading to robust innate immune activation. Notably, ssRNAOG induces the overexpression of MHC class I protein on macrophages, which recruits NK cells into the TME. The combination of ssRNAOG and 5-FU significantly suppressed tumor cell colony formation in vitro, demonstrating a synergistic antiproliferative effect. Transcriptomic and proteomic analyses revealed a significant upregulation of inflammatory cytokines and the activation of NF-κB and STAT1, which are indicative of M1-like polarization in macrophages. In vivo administration of both ssRNAOG and 5-FU revealed a marked reduction in tumor burden and an extension of survival in mice bearing xenograft PDAC tumors. Immunohistochemistry revealed a shift in macrophage polarization toward the M1-like phenotype, which is associated with enhanced proinflammatory responses and reduced tumor proliferation. These findings indicate that ssRNAOG, as a potent modulator of the TME that can sensitize resistant tumors to chemotherapy, presents a novel immunotherapeutic strategy for PDAC.

10 January 2025 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
KDKun Dai
Kun Dai
YXYang Xu
Yang Xu
YYYang Yang
Yang Yang
JSJianfeng Shen
Jianfeng Shen
XLXiaoguo Liu
Xiaoguo Liu
GYGuangbao Yao
Guangbao Yao